Aug 6, 2026 04:01PM
Jul 20, 2026 06:52AM
Jul 13, 2026 08:04AM
Jul 13, 2026 08:01AM
Jun 29, 2026 08:03AM
Jun 29, 2026 08:01AM
Jun 1, 2026 08:01AM Voyager gets FDA clearance for first tau gene therapy for Alzheimer's
Jun 1, 2026 08:00AM
May 13, 2026 06:02AM
May 13, 2026 06:01AM
May 7, 2026 04:01PM
Mar 9, 2026 04:01PM
Nov 10, 2025 08:01AM
May 6, 2025 04:01PM Voyager Reports First Quarter 2025 Financial and Operating Results
Mar 31, 2025 07:01AM
Mar 31, 2025 07:00AM
Nov 20, 2024 07:00AM
Aug 20, 2024 06:44AM
Aug 6, 2024 04:01PM
May 13, 2024 04:01PM
Apr 16, 2024 07:02AM Voyager Therapeutics (VYGR) Picks Development Candidate for GBA1 Program
Apr 16, 2024 07:00AM
Dec 6, 2023 07:05AM
Dec 6, 2023 07:00AM
Aug 3, 2023 07:00AM
May 9, 2023 07:00AM
Jan 9, 2023 07:44AM
Jan 9, 2023 07:00AM Neurocrine Biosciences and Voyager Therapeutics Enter Strategic Collaboration for Development and Commercialization of Voyager’s GBA1 Program and Other Next-Generation Gene Therapies for Neurologic
Sep 7, 2022 07:33AM
Sep 7, 2022 07:30AM
Aug 4, 2022 04:01PM
May 4, 2022 04:01PM
Mar 8, 2022 06:16AM
May 10, 2021 07:30AM
Apr 26, 2021 08:06AM Voyager Therapeutics (VYGR) Receives FDA Clearance of IND Application for Gene Therapy Candidate VY-HTT01 for Treatment of Huntington’s Disease
Apr 26, 2021 08:00AM
Feb 25, 2021 04:01PM
Feb 22, 2021 10:48AM
Feb 19, 2021 01:00PM
Feb 2, 2021 04:02PM
Feb 2, 2021 04:01PM
Dec 23, 2020 08:56AM Pre-Open Stock Movers 12/23: (OCGN) (UAVS) (SUPN) (CLNE) (CLRB) (FUBO) (NKLA) (more...)
Dec 22, 2020 04:20PM
Dec 22, 2020 04:17PM
Nov 9, 2020 04:00PM
Oct 13, 2020 09:27AM
Oct 12, 2020 05:21PM
Oct 12, 2020 04:04PM
Oct 12, 2020 04:01PM Voyager Therapeutics Provides Regulatory Update on VY-HTT01 Program
Sep 11, 2020 11:36AM

327,799 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All